LG Chem initiates phase 2 clinical trials in patients with defects in MC4R pathway causing obesity and hyperphagia
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Subscribe To Our Newsletter & Stay Updated